Woche 28 Express Certificate Memory on Pharma in USD/EUR/CHF
12M Express Certificate Memory on Pharma in USD/EUR/CHF
Compared to other sectors the pharmaceutical industry has been affected only slightly from Corona. Since then the courses of most of the companies are rising. Partially also due to "vaccine-fantasies".
This week we have developed a 12M Express Certificate with Memory Coupon. This product is equipped with different Barrier-Structures and a deacresing Coupon-Barrier to maximize the probability to ensure the high Coupons. On demand we'll structure this product including the popular features One Star and / or Lookback.
The memory coupons exceed the average dividend yields of
- Roche Holding AG (2.71%)
- Johnson Johnson (2.83%)
- Fresenius SE (1.84%)
- Pfizer AG (1.84%)
significantly.
Market opinion:
- weakening prices possible but not below the barrier level
- sideways trend or slightly increasing
12M Phoenix Memory on Pharma in CHF/EUR/USD
| Maturity | 12 months | ||
| Currency | CHF | EUR | USD |
| Denomination | 1000 CHF | 1000 EUR | 1000 USD |
| Underlying (Worst of) | Roche Holding AG (ROG SW) Johnson Johnson (JNJ US) Fresenius SE (FRE GR) Pfizer AG (PFE US) |
||
| Coupon memory with American Barrier 69% |
17.60% p.a. | 17.72% p.a. | 18.40% p.a. |
| Coupon memory with European Barrier 69% |
12.64% p.a. | 12.80% p.a. | 13.65% p.a. |
| Coupon Barrier | Q1: 90% Q2: 80% Q3: 70% Q4: 60% |
||
| Observation | Quarterly | ||
| Autocall | Q1: 100% Q2: 98% Q3: 96% Q4: 94% |
||
| Indication | 07.07.2020 | ||
| Size | CHF 1'000'000;-- | EUR1'000'000;-- | USD 1'000'000;-- |
| Issuer | Rating A- minimum | ||
| Issue Price | 100% | ||
| Finders Fee | Upon request | ||
We are happy to customize the relevant components exactly to your personal preferences. Please imagine that the indications can change day by day.
Are you interested in this topic? Please contact us and we will replicate your personal market view "tailor made" with our innovative products. We would be delighted to develop further hedging - arbitrage - or speculation opportunities for you. If you have already exact ideas of your favourite product we'll generate you the best conditions from more than 25 issuers.
Text und analysis by Florian Franz
Partner at Carat Solutions AG
Please find below the chart with the development of the relevant underlyings during the last 12 months:
